{"organizations": [], "uuid": "d54f6106ad85d87a82527665f20cba6a9c65918b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "", "site_section": "http://www.reuters.com/finance/personal-finance", "section_title": "Wealth, Personal Finance &amp; Money | Reuters.com", "url": "http://www.reuters.com/article/2015/10/09/ebola-johnsonjohnson-idUSL3N12925Y20151009", "country": "US", "title": "J&J starts clinical trial of Ebola vaccine in Sierra Leone", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "J&J starts clinical trial of Ebola vaccine in Sierra Leone | Reuters", "spam_score": 0.0, "site_type": "news", "published": "2015-10-09T10:14:00.000+03:00", "replies_count": 0, "uuid": "d54f6106ad85d87a82527665f20cba6a9c65918b"}, "author": "Reuters", "url": "http://www.reuters.com/article/2015/10/09/ebola-johnsonjohnson-idUSL3N12925Y20151009", "ord_in_thread": 0, "title": "J&J starts clinical trial of Ebola vaccine in Sierra Leone", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Oct 9 Johnson & Johnson said it has begun a safety and immunogenicity clinical trial of a preventive Ebola vaccine regimen in Sierra Leone.\nTrial recruitment is underway and the first volunteers have received their initial vaccine dose, the company said in a statement.\nThis is the first study conducted of Janssen's Ebola prime-boost vaccine regimen in a West African country affected by the recent Ebola epidemic, J&J said. (Reporting by Supriya Kurane in Bengaluru; Editing by Anupama Dwivedi)", "external_links": [], "published": "2015-10-09T10:14:00.000+03:00", "crawled": "2015-10-09T09:23:54.995+03:00", "highlightTitle": ""}